Market Cap (In INR)
658.89 Billion
Revenue (In INR)
126.67 Billion
Net Income (In INR)
17.95 Billion
Avg. Volume
4899.00
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 4409.9-6440.0
- PE
- -
- EPS
- -
- Beta Value
- 0.411
- ISIN
- INE540L01014
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Dr. Vikas Gupta
- Employee Count
- -
- Website
- https://www.alkemlabs.com
- Ipo Date
- 2015-12-23
- Details
- Alkem Laboratories Limited, a pharmaceutical company, engages in the development, manufacture, and sale of pharmaceutical and nutraceutical products in India and internationally. The company offers branded generics, generic drugs, active pharmaceutical ingredients, and biosimilars, and nutraceuticals in acute and chronic therapeutic areas comprising anti-infective, dermatology, cardiac, respiratory, gastro-intestinal, central nervous system, urology, and gynaecology, as well as vitamins, minerals, and nutrients; and pain analgesic, anti-diabetic, and neurology products. Alkem Laboratories Limited was incorporated in 1973 and is headquartered in Mumbai, India.
More Stocks
-
SOM
-
GOLF
-
688680
-
001316Zhejiang XiaSha Precision
001316
-
0O5HElekta AB (publ)
0O5H
-
SKRR
-
601138
-
UNTYUnity Bancorp, Inc.
UNTY